Argininosuccinate lyase: A new autoantigen in liver disease

Clinical and Experimental Immunology

Volumn 114, Issue 3, 1998, Pages 455-461

  Pelli, N ^c   Fensom, A H ^a   Slade, C ^a   Boa, F ^b   Mieli Vergani, G ^b   Vergani, D ^c,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anti liver cytosol; Antibody type 1; Argininosuccinate lyase; Autoimmune hepatitis

Indexed keywords

ARGININOSUCCINATE SYNTHASE; AUTOANTIGEN; MACROGOL; PRECIPITIN;

ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHRONIC HEPATITIS; DIAGNOSTIC VALUE; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HUMAN; IMMUNODIFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0031768677     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00754.x     Document Type: Article

References (28)

1. Manns M. Autoantibodies and antigens in liver diseases - updated. J Hepatol 1989; 9:272-80.
2. Meyer zum Büschenfelde KH, Lohse AW, Manns M et al. Autoimmunity and liver disease. Hepatol 1990; 12:354-63.
3. Mackay IR, Gershwin ME. Primary biliary cirrhosis: current knowledge, perspectives, and future directions. Semin Liver Dis 1989; 9:149-57.
4. Yeaman SJ, Fussey SP, Danner W et al. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet 1988; 1:1067-70.
5. Zurgil N, Bakimer R, Kaplan M et al. Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis. J Clin Immunol 1991; 11:239-45.
6. Homberg JC, Abuaf N, Bernard O et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of 'autoimmune' hepatitis. Hepatol 1987; 7:1333-9.
7. Alvarez F, Bernard O, Homberg JC et al. Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum. J Exp Med 1985; 161:1231-6.
8. Manns MP, Johnson EF, Griffin KJ et al. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450dbl. J Clin Invest 1989; 83:1066-72.
9. Ma Y, Peakman M, Lobo Yeo A et al. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol 1994; 97:94-99.
10. Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995; 90: 1206-11.
11. Martini E, Abuaf N, Cavalli F et al. Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatol 1988; 8:1662-6.
12. Han S, Tredger M, Gregorio GV et al. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 1995; 21:58-62.
13. Abuaf N, Johanet C, Chretien P et al. Characterization of the liver cytosol antigen type I reacting with autoantibodies in chronic active hepatitis. Hepatol 1992; 16:892-8.
14. Muratori L, Cataleta M, Muratori P et al. Detection of anti-liver cytosol antibody type I (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques J Immunol Methods 1995; 187:259-64.
15. Abuaf N, Johanet C, Soulier E, et al. Anti-liver cytosol antibodies in hepatology: autoimmune hepatitis, viral hepatitis C and graft-versus-host disease. In: Meyer zum Büschenfelde KH, ed. Immunology and liver. Falk symposium n. 70. Amsterdam: Kluwer Academic Publishers 1992:215-26.
16. De Duve C, Pressman BC, Gianetto R et al. Intracellular distribution patterns of enzymes in rat liver tissue. Biochem J 1955; 63:604-17.
17. Homberg JC, Andre C, Abuaf N. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis. Clin Exp Immunol 1984; 55:561-70.
18. Lowry OH, Rosebrough NJ, Farr AL et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-75.
19. Palekar AG, Mantagos S. Human liver arginino succinase purification and partial characterization. J Biol Chem 1981; 256:9192-4.
20. Luemmli UK. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 1970; 227:683-5.
21. Tedesco TA, Mellmun WL. Argininosuccinate synthetase activity in cells cultured from a citrullinemic subject. Proc Natl Acad Sci USA 1967; 57:829.
22. Sherwood RA, Titheradge AC, Richards DA. Measurement of plasma and urine amino acids by high-performance liquid chromatography with electrochemical detection using phenylisothiocyanate derivatization. J Chomatogr Biomed Appl 1990; 528:293-303.
23. Gregorio GV, Portmann B, Reid F et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatol 1997; 25:541-7.
24. Duclos Vallee JC, Hajoui O, Yarnamoto AM et al. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies. Gastroenterol 1995; 108:470-6.
25. Daw K, Ujihara N, Atkinson M et al. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 1996; 156:818-25.
26. Leung PS, Chuang DT, Wynn RM et al. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatol 1995; 22:505-13.
27. Alarcon Segovia D, Ruiz Arguelles A, Llorente L, Broken dogma: penetration of autoantibodies into living cells. Immunol Today 1996; 17:163-4.
28. Kaufman DL, Clare Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366:69-72.